SOPHiA GENETICS director plans sale of 18,750 shares

SOPHiA GENETICS SA (SOPH) received a notice under Rule 144 indicating that director Kathy L. Hibbs plans to sell up to 18,750 shares of common stock through Morgan Stanley Smith Barney LLC.

Rhea-AI Filing Summary

SOPHiA GENETICS SA (SOPH) received a notice under Rule 144 indicating that director Kathy L. Hibbs plans to sell up to 18,750 shares of common stock through Morgan Stanley Smith Barney LLC. The shares have an aggregate market value of $158,437.50, with an approximate sale date of August 25, 2026. Shares outstanding are listed as 85,127,825, and the securities relate to Restricted Stock Units originally dated June 18, 2025.

Key Figures

Shares to be sold: 18,750 shares of common stock Aggregate market value: $158,437.50 Shares outstanding: 85,127,825 shares +2 more

5 metrics

Shares to be sold 18,750 shares of common stock Planned sale under Rule 144 by director Kathy L. Hibbs

Aggregate market value $158,437.50 Value for the 18,750 SOPHiA GENETICS SA shares covered by the notice

Shares outstanding 85,127,825 shares Common shares outstanding of SOPHiA GENETICS SA shown in the Form 144 table

Approximate sale date 08/25/2026 Approximate date of sale for the shares under Rule 144

RSU reference date 06/18/2025 Date tied to the Restricted Stock Units related to the securities to be sold

Key Terms

Rule 144, Restricted Stock Units, aggregate market value, Securities To Be Sold

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 06/18/2025 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 18750 | 158437.50"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Securities To Be Sold financial

"144: Securities To Be Sold Common | 06/18/2025 | Restricted Stock Units"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider sale is being reported for SOPH under this Form 144?

Director Kathy L. Hibbs has filed a Rule 144 notice for a planned sale of up to 18,750 shares of SOPHiA GENETICS SA common stock, to be executed through Morgan Stanley Smith Barney LLC.

What is the aggregate market value of the SOPH shares covered by this Form 144?

The filing lists an aggregate market value of $158,437.50 for the 18,750 shares of SOPHiA GENETICS SA common stock that may be sold under this Rule 144 notice.

When are the SOPH shares expected to be sold under this Form 144?

The notice identifies an approximate sale date of August 25, 2026 for the planned disposition of the 18,750 shares of SOPHiA GENETICS SA common stock.

How many SOPH shares are shown as outstanding in this Form 144?

The Form 144 lists 85,127,825 shares of SOPHiA GENETICS SA common stock as outstanding in the same table that describes the planned Rule 144 sale.

What type of equity award is associated with the SOPH shares in this Form 144?

The securities to be sold are linked to Restricted Stock Units of SOPHiA GENETICS SA, with a referenced date of June 18, 2025 for those RSUs.

On which exchange are the SOPH shares planned to be sold according to the Form 144?

The Form 144 identifies NASDAQ as the securities exchange for the planned sale of SOPHiA GENETICS SA common stock under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 04:46 PM EDT Accepted by SEC EDGAR 08/25/2026 - 04:44 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001267487
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	KATHY L HIBBS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18750	158437.50	85127825	08/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/18/2025	Restricted Stock Units	Issuer			18750	06/18/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/01/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kathy L Hibbs
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)